Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precision Medicine Approaches to Renal Osteodystrophy

NCT05880914 is registered in ClinicalTrials.gov with Thomas Nickolas as lead sponsor.

NCT NCT05880914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05880914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precision Medicine Approaches to Renal Osteodystrophy
Lead sponsor
Thomas Nickolas
Phase
Observational
Overall status
Recruiting
Start date
December 21, 2022
Completion date
June 30, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone turnover rate disorder, chronic kidney diseases, ckd-mbd, renal osteodystrophy, secondary hyperparathyroidism